CURE’s lung cancer page is an extensive resource of cancer information featuring the latest lung cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on lung cancer.
October 28th 2024
This trial will assess an individualized neoantigen therapy plus Keytruda in some patients with non-small cell lung cancer.
October 18th 2024
FDA Fast Tracks Investigational Drug for Potential Approval in Lung Cancer Subtype
October 4th 2022Treatment with an investigational drug elicited a median progression-free survival (time from treatment until disease progression or death) of 8.9 months among patients with a form of unresectable or metastatic squamous non-small cell lung cancer, according to trial findings.